Evidence map›Paper›PMID 39654396›Full record

ArticleeLife2024

UGGT1-mediated reglucosylation of

Satoshi Ninagawa, Masaki Matsuo, Deng Ying, Shuichiro Oshita, Shinya Aso, Kazutoshi Matsushita, Mai Taniguchi, Akane Fueki, Moe Yamashiro, Kaoru Sugasawa and 8 more

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Satoshi Ninagawa *Biosignal Research Center, Kobe University, Kobe, Japan.ORCID https://orcid.org/0000-0002-8005-4716
Masaki Matsuo *Department of Bioresource Science, Graduate School of Agricultural Science, Kobe University, Kobe, Japan.ORCID https://orcid.org/0009-0004-6540-3238
Deng Ying *Department of Biophysics, Graduate School of Science, Kyoto University, Kyoto, Japan.
Shuichiro OshitaDepartment of Bioresource Science, Graduate School of Agricultural Science, Kobe University, Kobe, Japan.ORCID https://orcid.org/0009-0009-5815-0902
Shinya AsoDepartment of Bioresource Science, Graduate School of Agricultural Science, Kobe University, Kobe, Japan.ORCID https://orcid.org/0009-0001-7242-5193
Kazutoshi MatsushitaDepartment of Biophysics, Graduate School of Science, Kyoto University, Kyoto, Japan.
Mai TaniguchiDepartment of Biophysics, Graduate School of Science, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0009-0002-0140-8406
Akane FuekiDepartment of Bioresource Science, Graduate School of Agricultural Science, Kobe University, Kobe, Japan.ORCID https://orcid.org/0009-0003-8091-5103
Moe YamashiroDepartment of Bioresource Science, Graduate School of Agricultural Science, Kobe University, Kobe, Japan.ORCID https://orcid.org/0009-0006-8723-5436
Kaoru SugasawaBiosignal Research Center, Kobe University, Kobe, Japan.ORCID https://orcid.org/0000-0001-7937-4053
Shunsuke SaitoDepartment of Biophysics, Graduate School of Science, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0002-1331-811X
Koshi ImamiProteome Homeostasis Research Unit, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.ORCID https://orcid.org/0000-0002-7451-4982
Yasuhiko KizukaLaboratory of Glycobiochemistry, Institute for Glyco-core Research (iGCORE), Gifu University, Gifu, Japan.ORCID https://orcid.org/0000-0002-3181-9743
Tetsushi SakumaDivision of Integrated Sciences for Life, Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan.ORCID https://orcid.org/0000-0003-0396-1563
Takashi YamamotoDivision of Integrated Sciences for Life, Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, Japan.
Hirokazu YagiGraduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.ORCID https://orcid.org/0000-0001-9296-0225
Koichi KatoGraduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.ORCID https://orcid.org/0000-0001-7187-9612
Kazutoshi MoriDepartment of Biophysics, Graduate School of Science, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0001-7378-4019

Funding

Japan Science and Technology Agency 10.52926/JPMJCR21E3Japan Science and Technology Agency JPMJFR2255Japan Society for the Promotion of Science 17H01432Japan Society for the Promotion of Science 17H06419Japan Society for the Promotion of Science 18K06216Japan Society for the Promotion of Science 21H02625Japan Society for the Promotion of Science 22H00407Japan Society for the Promotion of Science 23H03838Japan Society for the Promotion of Science 24H00599
6 · The paper itself

Abstract

How the fate (folding versus degradation) of glycoproteins is determined in the endoplasmic reticulum (ER) is an intriguing question. Monoglucosylated glycoproteins are recognized by lectin chaperones to facilitate their folding, whereas glycoproteins exposing well-trimmed mannoses are subjected to glycoprotein ER-associated degradation (gpERAD); we have elucidated how mannoses are sequentially trimmed by EDEM family members (George et al., 2020; 2021 eLife). Although reglucosylation by UGGT was previously reported to have no effect on substrate degradation, here we directly tested this notion using cells with genetically disrupted UGGT1/2. Strikingly, the results showed that UGGT1 delayed the degradation of misfolded substrates and unstable glycoproteins including ATF6α. An experiment with a point mutant of UGGT1 indicated that the glucosylation activity of UGGT1 was required for the inhibition of early glycoprotein degradation. These and overexpression-based competition experiments suggested that the fate of glycoproteins is determined by a tug-of-war between structure formation by UGGT1 and degradation by EDEMs. We further demonstrated the physiological importance of UGGT1, since ATF6α cannot function properly without UGGT1. Thus, our work strongly suggests that UGGT1 is a central factor in ER protein quality control via the regulation of both glycoprotein folding and degradation.

Indexed as

Activating Transcription Factor 6Endoplasmic ReticulumEndoplasmic Reticulum-Associated DegradationGlycoproteinsPolysaccharidesProtein FoldingGlucosyltransferasesGlycosylationHEK293 CellsHumansMembrane ProteinsActivating Transcription Factor 6ATF6 protein, humanGlucosyltransferasesGlycoproteinsmannosylglycoprotein 1,3-glucosyltransferaseMembrane ProteinsPolysaccharidescell biologyEDEMER protein quality controlhumanprotein degradationprotein foldingUGGT1

Identifiers

PMID39654396
PMCPMC11630818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.